Integrity Alliance’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$546K Sell
3,919
-176
-4% -$24.6K 0.02% 421
2025
Q4
$503K Buy
+4,095
New +$498K 0.02% 460
2025
Q2
Sell
-1,872
Closed -$210K 550
2025
Q1
$210K Buy
+1,872
New +$193K 0.01% 579

Other funds holding GILD

Integrity Alliance's GILD Position: Q1 2026 in Review

Integrity Alliance reduced its Gilead Sciences (GILD) stake by 4.3% in Q1 2026, selling an estimated $24.6K and leaving 3,919 shares worth $546K. The position accounts for 0.02% of the portfolio, ranked #421.

Integrity Alliance first reported a position in GILD in Q1 2025 and has held it in 3 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Integrity Alliance held 3,919 shares of Gilead Sciences worth $546K as of Q1 2026.
  • Integrity Alliance sold 176 Gilead Sciences shares in Q1 2026, an estimated $24.6K.
  • Gilead Sciences made up 0.02% of Integrity Alliance's portfolio in Q1 2026, its #421 holding.
  • Integrity Alliance first reported a position in Gilead Sciences in Q1 2025 and has held it in 3 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.